[New] McKinsey estimates potential value creation of $200 billion to $500 billion by 2035 specifically from quantum computing applications in life sciences and drug discovery, driven by quantum's exceptional ability to perform first-principles calculations of molecular interactions.
Persistence Market Research
[New] The global pharmaceutical manufacturing sector, already valued in the hundreds of billions of dollars, is expected to reach $1 trillion in the coming years.
GlobeNewswire
[New] By 2026, we anticipate seeing generative AI used in drug discovery, materials science, and product design.
DeepUseCase
[New] In the coming years generative AI will become deeply integrated in product design, drug discovery, and even scientific research.
DeepUseCase
[New] Pharmaceutical leaders like Eli Lilly and Regeneron are seeing positive momentum, with Eli Lilly recently gaining FDA approval for its new weight-loss treatment, Foundayo, which is expected to drive further operational expansion.
FinancialContent
[New] Lessons learned from recent global disruptions continue to underscore the critical importance of a resilient pharmaceutical supply chain.
Pharma Guidelines
[New] New measures to help phase out animal testing in drug development will be supported by the [UK's] Medicines and Healthcare products Regulatory Agency.
Rise for Animals
[New] India Pharma 2026 aims to accelerate India's progress in the global pharmaceutical ecosystem by promoting innovation, collaboration, and future growth opportunities among policymakers, researchers, and industry leaders.
Guidely
A landmark Lancet study forecasts 39.1 million deaths directly caused by drug-resistant infections between 2025 and 2050, rounding to three infections every minute.
The Hawk News
In the Americas, U.S. output rose 5.2% in 2025 but is now projected at just 0.9% for 2026 and is being influenced by fading tariff effects and growing generic and biosimilar competition.
pharmexec
By 2026, we expect to see AI-powered platforms like Exscientia playing a crucial role in drug discovery.
Innovation Hub Live
Personalized medicine is projected to account for over 40% of all new drug approvals by 2028.
Innovation Hub Live
If a company pledges to invest in U.S. drug manufacturing in the coming years, its tariff rate will fall to 20%.
Edge and Odds -
Rising prevalence of drug-resistant infections and government-led monitoring initiatives drive a steady 5.47% CAGR through 2035.
Yahoo Finance
Donald Trump is threatening 100% tariffs on pharmaceutical companies that have not struck deals to lower US drug prices.
The Guardian
Bad news for the pharmaceutical sector, as reports suggest the US administration could be following through on Trump's threats from last year to impose 100% tariff rates on branded medicines as soon as today.
The Chartered Institute of Export & International Trade
With Americans used to paying the highest drug prices in the world, the implementation of most-favored-nation drug pricing agreements and other strategies will remain key points of discussion through 2026.
Akin Gump Strauss Hauer & Feld LLP
From OpenAI quietly cutting products to redirect compute, to pharma doubling down on AI-driven drug discovery, to lawsuits that could redefine how AI companies train their models, today's developments signal something bigger.
Tech Startups - Tech News, Tech Trends & Startup Fundin
The remarks signal how Washington is increasingly treating drug discovery as geopolitical infrastructure, raising the likelihood that pharma partnerships, licensing deals and supply chains tied to China will face growing policy scrutiny.
MM+M - Medical Marketing and Media
By 2030, 80% of pharmaceutical companies are projected to partner with TechBios, leveraging agentic AI and quantum computing to reduce R&D costs and failure rates.
IDC
